Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

Close
x

This content is available also in other languages
Dr. Karen Huebscher

Dr. Karen Huebscher

Chairwoman of the Audit Committee
Member of the Nomination and Governance Committee
Since 2012, elected until 2023
1963, Swiss and British citizen
Education (IMD, Lausanne), Ph.D. Natural Sciences Molecular Biology (ETH Zurich), Masters Degree, Animal Sciences (ETH Zurich)
 
Professional background
2014 - 2021 CEO Solvias Group2, Headquarter in Kaiseraugst, Switzerland
Since 2012 Founder and Managing Director of Fibula Medical AG
2009 - 2011 Member of the European Commercial Operations Leadership Team and Site Head Novartis Vaccines & Diagnostics, Basel; Head Public Health and Market Access Europe (Marketing & Sales); Board member European Vaccines Manufacturer's Association, Brussels.
2006 - 2009 Executive Committee Member, Head M&A/BD&L Division Vaccines & Diagnostics
2000 - 2006 Group Head Investor Relations Novartis
1995 - 2000 Various roles with increasing responsibility in R&D and Finance
 
Financial Expertise
CEO of Solvias AG2; Head Investor Relations Group, Novartis from 2000 to 2006, reporting directly to CFO and Head of Treasury, Member of the Disclosure Committee Novartis, Head Mergers and Acquisitions, Division Vaccines & Diagnostics, Novartis
 
Other activities
BBI Group2, Member of the Board Nonprofit organizations: SMG (Swiss Management Association)2, Member of the Board; IMD Foundation2, Member of the Board

 

1 public company
2 private company

empty cart | close cart
Your cart

Your cart is empty.

 
Update totals

Total:

 

Get a quote close form

 

 

 

|delete item